We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-2.5%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$333B
AUM Growth
-$5.65B
Cap. Flow
+$10.7B
Cap. Flow %
3.22%
Top 10 Hldgs %
17.75%
Holding
3,695
New
106
Increased
2,783
Reduced
461
Closed
115

Top Buys

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$727M
2
HD icon
Home Depot
HD
+$472M
3
PFE icon
Pfizer
PFE
+$362M
4
TXN icon
Texas Instruments
TXN
+$314M
5
LYB icon
LyondellBasell Industries
LYB
+$299M

Sector Composition

Rank Sector Weight
1 Technology 21.07%
2 Financials 12.97%
3 Healthcare 12.01%
4 Consumer Discretionary 10.22%
5 Industrials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATOS icon
3151
Atossa Therapeutics
ATOS
$21.6M
$393K ﹤0.01%
20,927
+965
+5% +$19.6K
REKR icon
3152
Rekor Systems
REKR
$90M
$392K ﹤0.01%
85,752
VMD icon
3153
Viemed Healthcare
VMD
$448M
$389K ﹤0.01%
78,035
XBIT icon
3154
XBiotech
XBIT
$68M
$387K ﹤0.01%
44,693
+6,085
+16% +$61K
PRTK
3155
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$386K ﹤0.01%
129,672
+7,019
+6% +$26.4K
OYST
3156
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$386K ﹤0.01%
33,139
+5,593
+20% +$66.6K
ZVRA icon
3157
Zevra Therapeutics
ZVRA
$594M
$384K ﹤0.01%
76,237
LTRPA
3158
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$381K ﹤0.01%
185,673
-813,865
-81% -$1.72M
KNBE
3159
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
$379K ﹤0.01%
16,422
VIRX
3160
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$377K ﹤0.01%
79,118
-6,942
-8% -$20.9K
DAKT icon
3161
Daktronics
DAKT
$1,000M
$376K ﹤0.01%
97,915
+5,830
+6% +$26.8K
ASXC
3162
DELISTED
Asensus Surgical, Inc.
ASXC
$376K ﹤0.01%
599,280
CVM icon
3163
CEL-SCI Corp
CVM
$21.8M
$373K ﹤0.01%
3,160
+10
+0.3% +$1.63K
URGN icon
3164
UroGen Pharma
URGN
$1.88B
$372K ﹤0.01%
42,689
THRX
3165
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$372K ﹤0.01%
32,229
+1,285
+4% +$13.7K
NMTR
3166
DELISTED
9 Meters Biopharma
NMTR
$371K ﹤0.01%
30,879
LENZ
3167
LENZ Therapeutics
LENZ
$157M
$366K ﹤0.01%
10,243
+4,156
+68% +$260K
NGMS
3168
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$366K ﹤0.01%
23,700
+1,317
+6% +$27.6K
EVGO icon
3169
EVgo
EVGO
$227M
$363K ﹤0.01%
28,193
+1,147
+4% +$11.5K
DIBS icon
3170
1stdibs.com
DIBS
$149M
$362K ﹤0.01%
45,273
+28,358
+168% +$273K
FRGI
3171
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$362K ﹤0.01%
48,349
+39
+0.1% +$373
PZN
3172
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$361K ﹤0.01%
44,989
+848
+2% +$7.73K
ZYXI
3173
DELISTED
Zynex
ZYXI
$359K ﹤0.01%
57,572
+3,576
+7% +$25.1K
PBFS icon
3174
Pioneer Bancorp
PBFS
$438M
$355K ﹤0.01%
33,726
+8,932
+36% +$98.1K
TCRT icon
3175
Alaunos Therapeutics
TCRT
$4.66M
$353K ﹤0.01%
3,604

Similar funds

Charles Schwab's Q1 2022 Portfolio in Review

As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,783 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.

  • Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
  • Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
  • Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
  • Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
  • Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
  • Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
  • Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.

Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.